-1.80%
Today
Loading 1D prices…
Company profile
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Tel Aviv, United States
Employees
6
Fiscal year end
1231
CIK
1801834
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| APVOAptevo Therapeutics Inc. Common Stock | $3.4M | $0.00 | — | -$87.27 | -3.17% | Buy |
| SXTCChina SXT Pharmaceuticals Inc. Class A Ordinary Shares | $3.4M | $1.1M | -545.24% | -$9.13 | +1.37% | Unrated |
| GOVXGeoVax Labs Inc. Common Stock | $3.3M | $2.5M | -862.34% | -$22.40 | -4.76% | Buy |
| HCWBHCW Biologics Inc. Common Stock | $3.5M | $54.2K | -14677.14% | -$10.63 | +10.24% | Buy |
| REVBRevelation Biosciences Inc. Common Stock | $3.5M | $0.00 | — | -$23.95 | -6.85% | Buy |